Skip to main content

Table 4 Comparison of serum lipid and PCSK9 concentrations in non-carriers versus carriers of a given PCSK9 variant values

From: Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations

PCSK9 Genotype

Total Cholesterol (mmol/L)

p-value

Triglyceride (mmol/L)

p-value

HDL Cholesterol (mmol/L)

p-value

LDL Cholesterol (mmol/L)

p-value

Serum PCSK9 (ng/mL)

p-value

Non-Carrier (n = 155)

5.67 ± 1.16

 

1.54 ± 0.73

 

1.19 ± 0.35

 

3.78 ± 1.00

 

327.2 ± 130.6

 

L10A53V

 

0.0047

 

0.56

 

0.63

 

0.0002

 

0.76

Carrier (n = 52)

5.13 ± 0.99

 

1.66 ± 0.82

 

1.21 ± 0.49

 

3.17 ± 0.92

 

326.5 ± 133.0

 

Non-Carrier (n = 150)

5.59 ± 1.19

 

1.54 ± 0.75

 

1.19 ± 0.37

 

3.70 ± 1.06

 

338.6 ± 136.2

 

I474V

 

0.13

 

0.57

 

0.86

 

0.056

 

0.033

Carrier (n = 57)

5.35 ± 0.98

 

1.61 ± 0.76

 

1.21 ± 0.44

 

3.42 ± 0.86

 

296.7 ± 111.0

 

Non-Carrier (n = 192)

5.56 ± 1.14

 

1.59 ± 0.77

 

1.20 ± 0.40

 

3.64 ± 1.01

 

328.1 ± 127.0

 

E670G

 

0.19

 

0.13

 

0.36

 

0.59

 

0.44

Non-Carrier (n = 15)

5.11 ± 1.12

 

1.27 ± 0.48

 

1.10 ± 0.30

 

3.45 ± 1.11

 

313.8 ± 177.9

 
  1. Variant values represent mean ± SD. Differences between groups were determined by Mann Whitney test with level of significance as p < 0.05.